Dorotea Fantl, MD

Dr. Fantl currently serves as Consultant Physician in the Hematology Department of the Hospital Italiano de Buenos Aires in Argentina after being Head of the Hematology Department. She is also Professor of Medicine at the Faculty of Medicine of the Italian Hospital of Buenos Aires and of the National Hematology Certification Training Program of the … Continued

Francesca Gay, MD, PhD

Dr. Francesca Gay is Associate Professor in the University of Torino, Department of Molecular Biotechnology and Health Sciences, and works as hematologist at the SSD Clinical trials in onco-ematology and multiple myeloma, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy. She completed her medical degree in 2004 and her … Continued

P. Joy Ho, MBBS

Prof. Joy Ho is Clinical Professor, University of Sydney, and Director of Research, Head of Myeloma Research Unit and Acting Director of Haematology at the Institute of Haematology, Royal Prince Alfred Hospital (RPAH), Australia. After Haematology training she was awarded the Oxford Nuffield Medical Fellowship in 1994 and completed doctoral studies at Oxford University. In … Continued

Sundar Jagannath, MD

Dr. Jagannath is the Director of the Multiple Myeloma Center of Excellence at Tisch Cancer Institute, Mount Sinai Hospital, New York, NY. He is also Professor of Medicine and Mount Sinai Endowed Chair for Multiple Myeloma at Mount Sinai School of Medicine. A board-certified specialist in internal medicine and medical oncology, Dr. Jagannath received his … Continued

Amrita Krishnan, MD

I am director of the Judy and Bernard Briskin Center for Myeloma research at the City of Hope Cancer Center. I have been at City of Hope for 22 years after completing a fellowship in stem cell transplantation there. I have served as past chair of the BMT CTN myeloma group, and been the PI … Continued

Pankaj Malhotra, MD

Pankaj Malhotra, MD is a Professor In-charge of Clinical Hematology at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. The institute was created by the special act of the Indian Parliament. The attached Nehru hospital to this institute has more than 2200 beds. The Department of Clinical Hematology annually sees approx. 46000 … Continued

Sonja Zweegman, MD, PhD

Dr. Zweegman works as a clinical hematologist as the head of the Department of Hematology at the VU University Medical Center Amsterdam UMC, Netherlands. and has a special interest in the treatment of patients with Multiple Myeloma. She is vice-chaiman of the HOVON Myeloma Working Group. Her clinical research is focused on the improvement of … Continued

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events